Literature DB >> 15317604

No substantial psychological impact of the diagnosis of Type 2 diabetes following targeted population screening: The Hoorn Screening Study.

M C Adriaanse1, F J Snoek, J M Dekker, A M W Spijkerman, G Nijpels, J W R Twisk, H M van der Ploeg, R J Heine.   

Abstract

AIMS: To examine the impact of the diagnosis of Type 2 diabetes on psychological well-being and perceived health status in subjects who participated in a targeted population-screening programme.
METHODS: This study was conducted within the framework of a screening project in the general (aged 50-75 years) Dutch population. The final study population consisted of 259 subjects with a high-risk score on the Symptom Risk Questionnaire; 116 of whom were subsequently detected with Type 2 diabetes and 143 who were non-diabetic. The impact was assessed approximately 2 weeks (shortly) and 6 and 12 months after the diagnosis, using the 12-item Well-Being Questionnaire (W-BQ12) and the Medical Outcomes Study Short Form 36 (SF-36), respectively. Analyses of co-variance (ancova) were used.
RESULTS: Approximately 2 weeks after the diagnosis, no significant mean differences were found on either the W-BQ12 or the SF-36, between the screening-detected Type 2 diabetes subjects and the non-diabetic subjects. Six months after the diagnosis, we found lower scores in the screening-detected Type 2 diabetes subjects compared with the non-diabetic subjects on the SF-36 dimensions Role Physical (mean difference (95% CI); -8.2 (-16.2; -0.1); P = 0.046) and Role Emotional (mean difference (95% CI); -7.9 (-15.3; -0.5); P = 0.038). One year after the test results, no significant mean differences were found between both groups on either instrument (W-BQ12; SF-36).
CONCLUSIONS: The diagnosis of Type 2 diabetes has no substantial adverse or positive effect on psychological well-being and perceived health status, shortly, and 6 and 12 months after the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15317604     DOI: 10.1111/j.1464-5491.2004.01276.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  17 in total

1.  Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study.

Authors:  Paul Gh Janssen; Kees J Gorter; Ronald P Stolk; Guy Ehm Rutten
Journal:  Br J Gen Pract       Date:  2009-01       Impact factor: 5.386

2.  Yield of opportunistic targeted screening for type 2 diabetes in primary care: the diabscreen study.

Authors:  Erwin P Klein Woolthuis; Wim J C de Grauw; Willem H E M van Gerwen; Henk J M van den Hoogen; Eloy H van de Lisdonk; Job F M Metsemakers; Chris van Weel
Journal:  Ann Fam Med       Date:  2009 Sep-Oct       Impact factor: 5.166

3.  How can we identify candidates at highest risk--to screen or not to screen?

Authors:  N C Barengo; J O Tuomilehto
Journal:  Herz       Date:  2016-05       Impact factor: 1.443

4.  TRAF4 functions as an intermediate of GITR-induced NF-kappaB activation.

Authors:  E M Esparza; R H Arch
Journal:  Cell Mol Life Sci       Date:  2004-12       Impact factor: 9.261

5.  Screening for diabetes: hope and despair.

Authors:  P T Sawicki
Journal:  Diabetologia       Date:  2012-04-19       Impact factor: 10.122

6.  Psychological well-being of gynecologic and obstetric patients: a validation of the 12-item Well-Being Questionnaire (W-BQ12).

Authors:  Rafał Watrowski; Anke Rohde
Journal:  Wien Klin Wochenschr       Date:  2014-07-04       Impact factor: 1.704

7.  Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior.

Authors:  Justin B Echouffo-Tcheugui; Rebecca K Simmons; A Toby Prevost; Kate M Williams; Ann-Louise Kinmonth; Nicholas J Wareham; Simon J Griffin
Journal:  Ann Fam Med       Date:  2015-03       Impact factor: 5.166

Review 8.  Quality of life in glaucoma and three other chronic diseases: a systematic literature review.

Authors:  Tim Mills; Simon K Law; John Walt; Patricia Buchholz; Jan Hansen
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

9.  The individual and combined effect of colorectal cancer and diabetes on health-related quality of life and sexual functioning: results from the PROFILES registry.

Authors:  Pauline A J Vissers; Melissa S Y Thong; Frans Pouwer; Brenda L den Oudsten; Grard A P Nieuwenhuijzen; Lonneke V van de Poll-Franse
Journal:  Support Care Cancer       Date:  2014-06-20       Impact factor: 3.603

10.  Are people with negative diabetes screening tests falsely reassured? Parallel group cohort study embedded in the ADDITION (Cambridge) randomised controlled trial.

Authors:  Charlotte A M Paddison; Helen C Eborall; Stephen Sutton; David P French; Joana Vasconcelos; A Toby Prevost; Ann-Louise Kinmonth; Simon J Griffin
Journal:  BMJ       Date:  2009-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.